Bringing Science To Early Stage InvestingSocial Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds. We focus on companies that leverage social and mobile technologies to drive generational changes in consumer and business behavior. Social Starts has been named the top fund under $100M since 2013, the 5th most active early stage fund worldwide of any size in 2015, and the 6th most active early stage fund in US tech in 2016 and 2017.
Joyance Partners is the first venture fund centered on individual, personal experience, rather than today’s medical industrial complex.
We expect to invest in very few companies in this area. But those few could actually transform the way we perceive and interact with the world.
Becoming active in early-stage health investing is a daunting prospect. How can any new fund entrant be of unique and useful service?